Literature DB >> 270997

Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus.

A Manoharan, L Gibson, B Rush, B J Feery.   

Abstract

A young man presenting with recurrent deep venous thrombosis was found to have a lupus type coagulation inhibitor. He showed neither clinical nor serological evidence of systemic lupus. The value of the Russell viper venom coagulation time in the detection of the inhibitor is demonstrated. Anticoagulant therapy has not caused any bleeding complication despite the presence of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 270997     DOI: 10.1111/j.1445-5994.1977.tb04410.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  8 in total

Review 1.  Testing for and clinical significance of anticardiolipin antibodies.

Authors:  S W Reddel; S A Krilis
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 2.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

3.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications.

Authors:  J A Rump; B Lang; H Engler; H H Peter
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

5.  Renal Vein Thrombosis and Selective Arterial or Venous Thrombolytic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

6.  The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.

Authors:  N E Anderson; M R Ali
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

7.  Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE.

Authors:  R A Asherson; C G Mackworth-Young; E N Harris; A E Gharavi; G R Hughes
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

8.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.